Protective efficacy induced by Mycobacterium bovis bacille Calmette-Guèrin can be augmented in an antigen independent manner by use of non-coding plasmid DNA.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Vaccine

• Publication date

  2006-01-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VACCINE.2005.07.115PMID 16314009
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of CpG in DNA vaccines

  2009cited by this paper
• Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c--a member of the esat-6 gene family.

  2005cited by this paper
• Jump-starting the immune system: prime-boosting comes of age.

  2004cited by this paper
• A Heterologous DNA Priming-Mycobacterium bovis BCG Boosting Immunization Strategy Using Mycobacterial Hsp70, Hsp65, and Apa Antigens Improves Protection against Tuberculosis in Mice

  2004cited by this paper
• Cellular immune responses induced in cattle by heterologous prime–boost vaccination using recombinant viruses and bacille Calmette–Guérin

  2004cited by this paper
• A DNA Prime-Mycobacterium bovis BCG Boost Vaccination Strategy for Cattle Induces Protection against Bovine Tuberculosis

  2003cited by this paper
• Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics.

  2003cited by this paper
• A DNA prime‐live vaccine boost strategy in mice can augment IFN‐γ responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis

  2003cited by this paper
• The complete genome sequence of Mycobacterium bovis

  2003cited by this paper
• Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

  2003cited by this paper
• Immunology of tuberculosis.

  2003cited by this paper
• Epitope Mapping of the Immunodominant Antigen TB10.4 and the Two Homologous Proteins TB10.3 and TB12.9, Which Constitute a Subfamily of the esat-6 Gene Family

  2002cited by this paper
• Correlation of ESAT-6-Specific Gamma Interferon Production with Pathology in Cattle following Mycobacterium bovis BCG Vaccination against Experimental Bovine Tuberculosis

  2002cited by this paper
• The global tuberculosis situation and the new control strategy of the World Health Organization. 1991.

  2001cited by this paper
• Failure to induce enhanced protection against tuberculosis by increasing T‐cell‐dependent interferon‐γ generation

  2001cited by this paper
• Tuberculosis vaccine development: recent progress.

  2001cited by this paper
• Enhanced Immunogenicity of CD4+ T-Cell Responses and Protective Efficacy of a DNA-Modified Vaccinia Virus Ankara Prime-Boost Vaccination Regimen for Murine Tuberculosis

  2001cited by this paper
• Improved Immunogenicity and Protective Efficacy of a Tuberculosis DNA Vaccine Encoding Ag85 by Protein Boosting

  2001cited by this paper
• Mixed immune response induced in rodents by two naked DNA genes coding for mycobacterial glycosylated proteins.

  2001cited by this paper
• Priming by DNA Immunization Augments Protective Efficacy of Mycobacterium bovis Bacille Calmette-Guerin against Tuberculosis

  2001cited by this paper
• Distinct Response Kinetics of Gamma Interferon and Interleukin-4 in Bovine Tuberculosis

  2000cited by this paper
• CpG Oligodeoxynucleotides and Interleukin-12 Improve the Efficacy of Mycobacterium bovis BCG Vaccination in Mice Challenged with M. tuberculosis

  2000cited by this paper
• Therapy of tuberculosis in mice by DNA vaccination

  1999cited by this paper
• Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria.

  1998cited by this paper
• Bovine Tuberculosis in Cattle and Badgers

  1997cited by this paper
• IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis.

  1997cited by this paper
• Contribution of CpG motifs to the immunogenicity of DNA vaccines.

  1997cited by this paper
• Protection against tuberculosis by a plasmid DNA vaccine.

  1997cited by this paper
• Interleukin 12 (IL-12) Is Crucial to the Development of Protective Immunity in Mice Intravenously Infected with Mycobacterium tuberculosis

  1997cited by this paper
• Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization

  1996cited by this paper
• Vaccination against tuberculosis by DNA injection

  1996cited by this paper
• The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection.

  1995cited by this paper
• Epidemiology of Mycobacterium bovis infection in animals and humans, with particular reference to Africa.

  1995cited by this paper
• Tuberculosis Pathogenesis, Protection, and Control

  1994cited by this paper
• The BCG Experience: Implications for Future Vaccines against Tuberculosis

  1994cited by this paper
• An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

  1993cited by this paper
• The global tuberculosis situation and the new control strategy of the World Health Organization.

  1991cited by this paper
• A selective oleic acid albumin agar medium for the cultivation of Mycobacterium bovis

  1977cited by this paper
• Materials and Methods Briefdefinitive Report Disseminated Tuberculosis in Interferon 7 Gene-disrupted Mice

  year unknowncited by this paper

• Bacillus Calmette-Guérin (BCG)-Induced Protection in Brain Disorders

  2024cites this paper
• The effect of BCG vaccination on macrophage phenotype in a mouse model of intranasal Mycobacterium bovis challenge.

  2020cites this paper
• Tuberculosis vaccine candidates based on mycobacterial cell envelope components.

  2019cites this paper
• Vesicular Stomatitis Virus-Vectored Multi-Antigen Tuberculosis Vaccine Limits Bacterial Proliferation in Mice following a Single Intranasal Dose

  2017cites this paper
• Parenteral adenoviral boost enhances BCG induced protection, but not long term survival in a murine model of bovine TB.

  2016cites this paper
• Potential Role of M. tuberculosis Specific IFN-γ and IL-2 ELISPOT Assays in Discriminating Children with Active or Latent Tuberculosis

  2012cites this paper
• Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis.

  2012cites this paper
• Immunotherapy for TB.

  2012cites this paper
• Identification of biomarkers in protection against bovine tuberculosis through global gene expression analysis in vaccinated and infected mice and cattle

  2012cites this paper
• Novel vaccine prime and selective BCG boost: a new tuberculosis vaccine strategy for infants of HIV-infected mothers.

  2010cites this paper
• Burkholderia pseudomallei Proteins Presented by Monocyte-Derived Dendritic Cells Stimulate Human Memory T Cells In Vitro

  2010cites this paper
• Suppression of the Immune Response Against Tuberculosis by Natural T Regulatory Cells

  2007cites this paper
• A novel method to screen genomic libraries that combines genomic immunization with the prime-boost strategy.

  2007cites this paper
• Development of vaccines against bovine tuberculosis

  2006influential citation
• The nature of memory CD8+ T-cell responses in bovine tuberculosis

  2006cites this paper
• Development of cattle TB vaccines in the UK.

  2006cites this paper